Compile Data Set for Download or QSAR
Report error Found 24 Enz. Inhib. hit(s) with all data for entry = 11611
TargetTyrosine-protein phosphatase non-receptor type 11(Human)
Zhejiang Hisun Pharmaceutical

US Patent
LigandPNGBDBM633155(US20230348467, Compound 5)
Affinity DataIC50: 1nMAssay Description:he experimental process was briefly described as follows: Test compounds were first dissolved in DMSO to prepare storage solutions. The reaction was ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetTyrosine-protein phosphatase non-receptor type 11(Human)
Zhejiang Hisun Pharmaceutical

US Patent
LigandPNGBDBM633161(US20230348467, Compound 9)
Affinity DataIC50: 1nMAssay Description:he experimental process was briefly described as follows: Test compounds were first dissolved in DMSO to prepare storage solutions. The reaction was ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetTyrosine-protein phosphatase non-receptor type 11(Human)
Zhejiang Hisun Pharmaceutical

US Patent
LigandPNGBDBM633168(US20230348467, Compound 23)
Affinity DataIC50: 2nMAssay Description:he experimental process was briefly described as follows: Test compounds were first dissolved in DMSO to prepare storage solutions. The reaction was ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetTyrosine-protein phosphatase non-receptor type 11(Human)
Zhejiang Hisun Pharmaceutical

US Patent
LigandPNGBDBM633178(US20230348467, Compound 51)
Affinity DataIC50: 3nMAssay Description:he experimental process was briefly described as follows: Test compounds were first dissolved in DMSO to prepare storage solutions. The reaction was ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetTyrosine-protein phosphatase non-receptor type 11(Human)
Zhejiang Hisun Pharmaceutical

US Patent
LigandPNGBDBM633172(US20230348467, Compound 29)
Affinity DataIC50: 3nMAssay Description:he experimental process was briefly described as follows: Test compounds were first dissolved in DMSO to prepare storage solutions. The reaction was ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetTyrosine-protein phosphatase non-receptor type 11(Human)
Zhejiang Hisun Pharmaceutical

US Patent
LigandPNGBDBM633173(US20230348467, Compound 30)
Affinity DataIC50: 3nMAssay Description:he experimental process was briefly described as follows: Test compounds were first dissolved in DMSO to prepare storage solutions. The reaction was ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetTyrosine-protein phosphatase non-receptor type 11(Human)
Zhejiang Hisun Pharmaceutical

US Patent
LigandPNGBDBM633177(US20230348467, Compound 46)
Affinity DataIC50: 3nMAssay Description:he experimental process was briefly described as follows: Test compounds were first dissolved in DMSO to prepare storage solutions. The reaction was ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetTyrosine-protein phosphatase non-receptor type 11(Human)
Zhejiang Hisun Pharmaceutical

US Patent
LigandPNGBDBM633167(US20230348467, Compound 17)
Affinity DataIC50: 4nMAssay Description:he experimental process was briefly described as follows: Test compounds were first dissolved in DMSO to prepare storage solutions. The reaction was ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetTyrosine-protein phosphatase non-receptor type 11(Human)
Zhejiang Hisun Pharmaceutical

US Patent
LigandPNGBDBM633158(US20230348467, Compound 6)
Affinity DataIC50: 4nMAssay Description:he experimental process was briefly described as follows: Test compounds were first dissolved in DMSO to prepare storage solutions. The reaction was ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetTyrosine-protein phosphatase non-receptor type 11(Human)
Zhejiang Hisun Pharmaceutical

US Patent
LigandPNGBDBM633159(US20230348467, Compound 8 | US20230348467, Compoun...)
Affinity DataIC50: 5nMAssay Description:he experimental process was briefly described as follows: Test compounds were first dissolved in DMSO to prepare storage solutions. The reaction was ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetTyrosine-protein phosphatase non-receptor type 11(Human)
Zhejiang Hisun Pharmaceutical

US Patent
LigandPNGBDBM633169(US20230348467, Compound 24)
Affinity DataIC50: 5nMAssay Description:he experimental process was briefly described as follows: Test compounds were first dissolved in DMSO to prepare storage solutions. The reaction was ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetTyrosine-protein phosphatase non-receptor type 11(Human)
Zhejiang Hisun Pharmaceutical

US Patent
LigandPNGBDBM633170(US20230348467, Compound 25)
Affinity DataIC50: 5nMAssay Description:he experimental process was briefly described as follows: Test compounds were first dissolved in DMSO to prepare storage solutions. The reaction was ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetTyrosine-protein phosphatase non-receptor type 11(Human)
Zhejiang Hisun Pharmaceutical

US Patent
LigandPNGBDBM633162(US20230348467, Compound 10)
Affinity DataIC50: 7nMAssay Description:he experimental process was briefly described as follows: Test compounds were first dissolved in DMSO to prepare storage solutions. The reaction was ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetTyrosine-protein phosphatase non-receptor type 11(Human)
Zhejiang Hisun Pharmaceutical

US Patent
LigandPNGBDBM633171(US20230348467, Compound 27)
Affinity DataIC50: 7nMAssay Description:he experimental process was briefly described as follows: Test compounds were first dissolved in DMSO to prepare storage solutions. The reaction was ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetTyrosine-protein phosphatase non-receptor type 11(Human)
Zhejiang Hisun Pharmaceutical

US Patent
LigandPNGBDBM633164(US20230348467, Compound 12)
Affinity DataIC50: 8nMAssay Description:he experimental process was briefly described as follows: Test compounds were first dissolved in DMSO to prepare storage solutions. The reaction was ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetTyrosine-protein phosphatase non-receptor type 11(Human)
Zhejiang Hisun Pharmaceutical

US Patent
LigandPNGBDBM633175(US20230348467, Compound 32)
Affinity DataIC50: 10nMAssay Description:he experimental process was briefly described as follows: Test compounds were first dissolved in DMSO to prepare storage solutions. The reaction was ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetTyrosine-protein phosphatase non-receptor type 11(Human)
Zhejiang Hisun Pharmaceutical

US Patent
LigandPNGBDBM633165(US20230348467, Compound 13)
Affinity DataIC50: 10nMAssay Description:he experimental process was briefly described as follows: Test compounds were first dissolved in DMSO to prepare storage solutions. The reaction was ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetTyrosine-protein phosphatase non-receptor type 11(Human)
Zhejiang Hisun Pharmaceutical

US Patent
LigandPNGBDBM633179(US20230348467, Compound 53)
Affinity DataIC50: 11nMAssay Description:he experimental process was briefly described as follows: Test compounds were first dissolved in DMSO to prepare storage solutions. The reaction was ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetTyrosine-protein phosphatase non-receptor type 11(Human)
Zhejiang Hisun Pharmaceutical

US Patent
LigandPNGBDBM633159(US20230348467, Compound 8 | US20230348467, Compoun...)
Affinity DataIC50: 14nMAssay Description:he experimental process was briefly described as follows: Test compounds were first dissolved in DMSO to prepare storage solutions. The reaction was ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetTyrosine-protein phosphatase non-receptor type 11(Human)
Zhejiang Hisun Pharmaceutical

US Patent
LigandPNGBDBM633163(US20230348467, Compound 11)
Affinity DataIC50: 17nMAssay Description:he experimental process was briefly described as follows: Test compounds were first dissolved in DMSO to prepare storage solutions. The reaction was ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetTyrosine-protein phosphatase non-receptor type 11(Human)
Zhejiang Hisun Pharmaceutical

US Patent
LigandPNGBDBM633166(US20230348467, Compound 15)
Affinity DataIC50: 24nMAssay Description:he experimental process was briefly described as follows: Test compounds were first dissolved in DMSO to prepare storage solutions. The reaction was ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetTyrosine-protein phosphatase non-receptor type 11(Human)
Zhejiang Hisun Pharmaceutical

US Patent
LigandPNGBDBM633176(US20230348467, Compound 38)
Affinity DataIC50: 27nMAssay Description:he experimental process was briefly described as follows: Test compounds were first dissolved in DMSO to prepare storage solutions. The reaction was ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetTyrosine-protein phosphatase non-receptor type 11(Human)
Zhejiang Hisun Pharmaceutical

US Patent
LigandPNGBDBM633154(US20230348467, Compound 2)
Affinity DataIC50: 29nMAssay Description:he experimental process was briefly described as follows: Test compounds were first dissolved in DMSO to prepare storage solutions. The reaction was ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetTyrosine-protein phosphatase non-receptor type 11(Human)
Zhejiang Hisun Pharmaceutical

US Patent
LigandPNGBDBM38019(US10093646, Compound 1 | US10301278, Example 00003...)
Affinity DataIC50: 128nMAssay Description:he experimental process was briefly described as follows: Test compounds were first dissolved in DMSO to prepare storage solutions. The reaction was ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent